{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:27:42Z","timestamp":1775597262367,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,18]]},"DOI":"10.7759\/cureus.37774","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T16:10:39Z","timestamp":1681834239000},"source":"Crossref","is-referenced-by-count":5,"title":["Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Kusum","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritesh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S","family":"Toppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanki","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakhan","family":"Majhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh D","year":"2019","unstructured":"Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019, 79:365-79. 10.1007\/s40265-019-1064-1","journal-title":"Drugs"},{"key":"ref2","article-title":"Acute Kidney Injury","author":"Wakar SS","year":"2022","unstructured":"Wakar SS, Bonventre JV. Acute Kidney Injury. Harrison's Principle of Internal Medicine. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J (ed): McGraw-Hill, 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019","volume":"74","author":"Ku E","year":"2019","unstructured":"Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019, 74:120-31. 10.1053\/j.ajkd.2018.12.044","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.14469","article-title":"Nighttime hypertension in chronic kidney disease-are we in the dark without ambulatory blood pressure monitoring?","volume":"5","author":"Mayeda L","year":"2022","unstructured":"Mayeda L, Rivara MB. Nighttime hypertension in chronic kidney disease-are we in the dark without ambulatory blood pressure monitoring?. JAMA Netw Open. 2022, 5:e2214469. 10.1001\/jamanetworkopen.2022.14469","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04330418","article-title":"Clinical Pharmacology of antihypertensive therapy for the treatment of hypertension in CKD","volume":"14","author":"Sinha AD","year":"2019","unstructured":"Sinha AD, Agarwal R. Clinical Pharmacology of antihypertensive therapy for the treatment of hypertension in CKD. Clin J Am Soc Nephrol. 2019, 14:757-64. 10.2215\/CJN.04330418","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6653851","article-title":"Effects of L-\/N-type calcium channel blockers on angiotensin II-renin feedback in hypertensive patients","volume":"2020","author":"Kawabata Y","year":"2020","unstructured":"Kawabata Y, Soeki T, Ito H, et al.. Effects of L-\/N-type calcium channel blockers on angiotensin II-renin feedback in hypertensive patients. Int J Hypertens. 2020, 2020:6653851. 10.1155\/2020\/6653851","journal-title":"Int J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease","volume":"72","author":"Fujita T","year":"2007","unstructured":"Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, Isshiki M, Takahashi K. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int. 2007, 72:1543-9. 10.1038\/sj.ki.5002623","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1874241600902010031","article-title":"Change of glomerular hemodynamics in patients with advanced chronic kidney disease after cilnidipine therapy","volume":"3","author":"Satomura A","year":"2009","unstructured":"Satomura A, Fujita T, Fuke Y, Wada Y, Matsumoto K. Change of glomerular hemodynamics in patients with advanced chronic kidney disease after cilnidipine therapy. Open Clin Chem J. 2009, 3:31-6. 10.2174\/1874241600902010031","journal-title":"Open Clin Chem J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dialis.2012.04.001","article-title":"Cilnidipine effectively reduces low-grade albuminuria in hypertensive chronic kidney disease patients","volume":"34","author":"Malleshappa P","year":"2013","unstructured":"Malleshappa P. Cilnidipine effectively reduces low-grade albuminuria in hypertensive chronic kidney disease patients. Dialisis Y Trasplante. 2013, 34:2-6. 10.1016\/j.dialis.2012.04.001","journal-title":"Dialisis Y Trasplante"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140816866","article-title":"L\/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease","volume":"14","author":"Kanaoka T","year":"2013","unstructured":"Kanaoka T, Tamura K, Wakui H, et al.. L\/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease. Int J Mol Sci. 2013, 14:16866-81. 10.3390\/ijms140816866","journal-title":"Int J Mol Sci"},{"key":"ref11","article-title":"Comparison of usage patterns and outcomes by dual type calcium channel blockers in patients with chronic kidney disease","volume":"30","author":"Oh MR","year":"2020","unstructured":"Oh MR, Ahn HL, Choi S, La HO. Comparison of usage patterns and outcomes by dual type calcium channel blockers in patients with chronic kidney disease. Korean J Clin Pharm. 2020, 30:259-63.","journal-title":"Korean J Clin Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000420","article-title":"Switching to an L\/N-type calcium channel blocker shows renoprotective effects in patients with chronic kidney disease: the Kyoto Cilnidipine Study","volume":"40","author":"Hatta T","year":"2012","unstructured":"Hatta T, Takeda K, Shiotsu Y, et al.. Switching to an L\/N-type calcium channel blocker shows renoprotective effects in patients with chronic kidney disease: the Kyoto Cilnidipine Study. J Int Med Res. 2012, 40:1417-28. 10.1177\/147323001204000420","journal-title":"J Int Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases","volume":"27","author":"Kojima S","year":"2004","unstructured":"Kojima S, Shida M, Yokoyama H. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. Hypertens Res. 2004, 27:379-85. 10.1291\/hypres.27.379","journal-title":"Hypertens Res"},{"key":"ref14","article-title":"A meta analysis of the efficacy & safety of cilnidipine in Chinese patients with mild to moderate essential hypertension","volume":"6","author":"Guoliang X","unstructured":"Guoliang X, Haidi W, Bing D, Ling Q. A meta analysis of the efficacy & safety of cilnidipine in Chinese patients with mild to moderate essential hypertension. J Pharm Pharmacol. 6:2393-9.","journal-title":"J Pharm Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2013.11.001","article-title":"The fourth-generation Calcium channel blocker: cilnidipine","volume":"65","author":"Chandra KS","year":"2013","unstructured":"Chandra KS, Ramesh G. The fourth-generation Calcium channel blocker: cilnidipine. Indian Heart J. 2013, 65:691-5. 10.1016\/j.ihj.2013.11.001","journal-title":"Indian Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-021-00224-8","article-title":"Effectiveness and effect on renal parameters of amlodipine vs. other dihydropyridine calcium channel blockers in patients with essential hypertension: retrospective observational study based on real-world evidence from electronic medical records","volume":"10","author":"Jadhav U","year":"2021","unstructured":"Jadhav U, Mohanan PP, Almeida AF, et al.. Effectiveness and effect on renal parameters of amlodipine vs. other dihydropyridine calcium channel blockers in patients with essential hypertension: retrospective observational study based on real-world evidence from electronic medical records. Cardiol Ther. 2021, 10:465-80. 10.1007\/s40119-021-00224-8","journal-title":"Cardiol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27847","article-title":"Renal function in hypertensive patients receiving cilnidipine and L-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies","volume":"14","author":"Srivathsan M","year":"2022","unstructured":"Srivathsan M, Vardhan V, Naseem A, Patil S, Rai V, Langade DG. Renal function in hypertensive patients receiving cilnidipine and L-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies. Cureus. 2022, 14:e27847. 10.7759\/cureus.27847","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.19080\/JOCCT.2018.10.555796","article-title":"Assessment of effects of amlodipine and cilnidipine on urea and creatinine levels in hypertensive patients - a comparative study","volume":"10","author":"Sarkar S","year":"2018","unstructured":"Sarkar S, Srivastava V, Mohanty M. Assessment of effects of amlodipine and cilnidipine on urea and creatinine levels in hypertensive patients - a comparative study. J Cardiol Cardiovasc Ther. 2018, 10:555796. 10.19080\/JOCCT.2018.10.555796","journal-title":"J Cardiol Cardiovasc Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/2468-838X.303758","article-title":"Effect of L\/N-type calcium channel blocker (cilnidipine) on oxidative stress in nitric oxide-deficient hypertensive rats","volume":"2","author":"Shaikh GB","unstructured":"Shaikh GB, Hipargi S, Dewan SA. Majid,  Biradar MS, Das KK. Effect of L\/N-type calcium channel blocker (cilnidipine) on oxidative stress in nitric oxide-deficient hypertensive rats. 2:1. 10.4103\/2468-838X.303758"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14740\/cr497w","article-title":"Serum triglyceride lowering effect of cilnidipine in patients with essential hypertension","volume":"7","author":"Kumar P","year":"2016","unstructured":"Kumar P, Das A, Chandra S, Gari M, Keshri US, Kumari K. Serum triglyceride lowering effect of cilnidipine in patients with essential hypertension. Cardiol Res. 2016, 7:173-7. 10.14740\/cr497w","journal-title":"Cardiol Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-020-00211-w","article-title":"Effectiveness of amlodipine on blood pressure control in hypertensive patients in India: a real-world, retrospective study from electronic medical records","volume":"7","author":"Khan MY","year":"2020","unstructured":"Khan MY, Pandit S, Ray S, et al.. Effectiveness of amlodipine on blood pressure control in hypertensive patients in India: a real-world, retrospective study from electronic medical records. Drugs Real World Outcomes. 2020, 7:281-93. 10.1007\/s40801-020-00211-w","journal-title":"Drugs Real World Outcomes"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.5455\/njppp.2018.8.0723228072018","article-title":"A randomized open-label study to compare the effects of amlodipine and cilnidipine on heart rate and proteinuria in subjects with hypertension with proteinuria","volume":"8","author":"Shanbhag AD","year":"2018","unstructured":"Shanbhag AD, Gowda HN, Laxmegowda. A randomized open-label study to compare the effects of amlodipine and cilnidipine on heart rate and proteinuria in subjects with hypertension with proteinuria. Natl J Physiol Pharm Pharmacol. 2018, 8:1485-90.","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref23","article-title":"To evaluate effect of olmesartan versus cilnidipine on urinary microalbumin level in patients of hypertension with type II diabetes mellitus","volume":"4","author":"Anand","year":"2021","unstructured":"Anand, Bajpai A , Aboobecker SPA. To evaluate effect of olmesartan versus cilnidipine on urinary microalbumin level in patients of hypertension with type II diabetes mellitus. Int J Health Clin Res. 2021, 4:18-21.","journal-title":"Int J Health Clin Res"},{"key":"ref24","article-title":"An open label prospective study on evaluation of safety and efficacy of cilnidipine over amlodipine in Stage 1 hypertensive patients","volume":"18","author":"Harlalka S","year":"2020","unstructured":"Harlalka S , Roy UK , Majumdar G , Das K , Mandal P . An open label prospective study on evaluation of safety and efficacy of cilnidipine over amlodipine in Stage 1 hypertensive patients. Kathmandu Univ Med J (KUMJ). 2020, 18:42-8.","journal-title":"Kathmandu Univ Med J (KUMJ)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149711-blood-pressure-reducing-potential-and-renoprotective-action-of-cilnidipine-among-hypertensive-patients-suffering-from-chronic-kidney-disease-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:32Z","timestamp":1707508532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149711-blood-pressure-reducing-potential-and-renoprotective-action-of-cilnidipine-among-hypertensive-patients-suffering-from-chronic-kidney-disease-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.37774","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}